123 related articles for article (PubMed ID: 18197949)
21. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
[TBL] [Abstract][Full Text] [Related]
22. Measurement of problem behaviour during medication evaluations.
Zarcone J; Napolitano D; Valdovinos M
J Intellect Disabil Res; 2008 Dec; 52(12):1015-28. PubMed ID: 18717764
[TBL] [Abstract][Full Text] [Related]
23. Mood stabilizer combinations: a review of safety and efficacy.
Freeman MP; Stoll AL
Am J Psychiatry; 1998 Jan; 155(1):12-21. PubMed ID: 9433333
[TBL] [Abstract][Full Text] [Related]
24. Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review.
Yeh YC; Ouyang WC
Kaohsiung J Med Sci; 2012 Apr; 28(4):185-93. PubMed ID: 22453066
[TBL] [Abstract][Full Text] [Related]
25. Anticonvulsants for Psychiatric Disorders in Children and Adolescents: A Systematic Review of Their Efficacy.
Davico C; Canavese C; Vittorini R; Gandione M; Vitiello B
Front Psychiatry; 2018; 9():270. PubMed ID: 29988399
[No Abstract] [Full Text] [Related]
26. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
Matson JL; Bielecki J; Mayville SB; Matson ML
Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
[TBL] [Abstract][Full Text] [Related]
27. Antiepileptic drugs and mood stability.
Amann B; Grunze H; Vieta E; Trimble M
Clin EEG Neurosci; 2007 Apr; 38(2):116-23. PubMed ID: 17515177
[TBL] [Abstract][Full Text] [Related]
28. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
[TBL] [Abstract][Full Text] [Related]
29. Mood stabilizers in pregnancy: a systematic review.
Galbally M; Roberts M; Buist A;
Aust N Z J Psychiatry; 2010 Nov; 44(11):967-77. PubMed ID: 21034180
[TBL] [Abstract][Full Text] [Related]
30. Pharmacists' medicines-related interventions for people with intellectual disabilities: a narrative review.
O'Dwyer M; Meštrović A; Henman M
Int J Clin Pharm; 2015 Aug; 37(4):566-78. PubMed ID: 25903938
[TBL] [Abstract][Full Text] [Related]
31. A systematic review on the impact of psychotropic drugs on electroencephalogram waveforms in psychiatry.
Aiyer R; Novakovic V; Barkin RL
Postgrad Med; 2016 Sep; 128(7):656-64. PubMed ID: 27467441
[TBL] [Abstract][Full Text] [Related]
32. Management of psychotropic medications in adults with intellectual disability: a scoping review protocol.
Costello A; Hehir C; Sharma D; Hudson E; Doody O; Kelly D
HRB Open Res; 2021; 4():30. PubMed ID: 34693205
[No Abstract] [Full Text] [Related]
33. Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: a systematic review.
Ward F; Tharian P; Roy M; Deb S; Unwin GL
Res Dev Disabil; 2013 Dec; 34(12):4293-303. PubMed ID: 24171827
[TBL] [Abstract][Full Text] [Related]
34. Challenges and Promises of Pediatric Psychopharmacology.
Giles LL; Martini DR
Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
[TBL] [Abstract][Full Text] [Related]
35. Association between mood-stabilizing medication and mental health resource use in the management of acute mania.
Sajatovic M; Gerhart C; Semple W
Psychiatr Serv; 1997 Aug; 48(8):1037-41. PubMed ID: 9255836
[TBL] [Abstract][Full Text] [Related]
36. Special care units for dementia individuals with behavioural problems.
Lai CK; Yeung JH; Mok V; Chi I
Cochrane Database Syst Rev; 2009 Oct; (4):CD006470. PubMed ID: 19821370
[TBL] [Abstract][Full Text] [Related]
37. Proxy and self-reported Quality of Life in adults with intellectual disabilities: Impact of psychiatric symptoms, problem behaviour, psychotropic medication and unmet needs.
Koch AD; Vogel A; Becker T; Salize HJ; Voss E; Werner A; Arnold K; Schützwohl M
Res Dev Disabil; 2015; 45-46():136-46. PubMed ID: 26233765
[TBL] [Abstract][Full Text] [Related]
38. The efficacy and use of anticonvulsants in mood disorders.
Dunn RT; Frye MS; Kimbrell TA; Denicoff KD; Leverich GS; Post RM
Clin Neuropharmacol; 1998; 21(4):215-35. PubMed ID: 9704164
[TBL] [Abstract][Full Text] [Related]
39. The overweight: obesity and plasma lipids in adults with intellectual disability and mental illness.
Gazizova D; Puri BK; Singh I; Dhaliwal R
J Intellect Disabil Res; 2012 Sep; 56(9):895-901. PubMed ID: 21883600
[TBL] [Abstract][Full Text] [Related]
40. [Use of antiepileptic drugs in bipolar disorder].
Pérez-Ceballos MA; Vega-Gil N; Sánchez MB; Armijo JA
Actas Esp Psiquiatr; 2006; 34(1):55-64. PubMed ID: 16525906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
